TENX Oxygen Biotherapeutics Inc

Tenax Therapeutics Inc is a specialty pharmaceutical company. The Company is engaged in developing & commercializing pharmaceutical products for critical care patients and its products include Levosimendan & Oxycyte.

$1.17
As of 12/03/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/15/2010
Outstanding shares:  25,206,914
Average volume:  81,275
Market cap:   $29,744,159
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    88032L209
ISIN:        US88032L2097
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   4.08
PS ratio:   0.00
Return on equity:   -299.18%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy